Soleus Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$270K	Sell	10,000 -290,034	-97%	-$9.75M	0.01%	89
2025 Q4	$12.9M	Sell	300,034 -29,976	-9%	-$1.13M	0.55%	46
2025 Q3	$9.35M	Sell	330,010 -328,135	-50%	-$9.82M	0.5%	48
2025 Q2	$12.3M	Sell	658,145 -472,534	-42%	-$8.96M	0.85%	35
2025 Q1	$20.3M	Hold	1,130,679	–	–	1.59%	22
2024 Q4	$19M	Buy	1,130,679 +195,891	+21%	+$3.76M	1.44%	25
2024 Q3	$15.1M	Sell	934,788 -108,909	-10%	-$1.28M	1.26%	32
2024 Q2	$8.58M	Buy	1,043,697 +119,498	+13%	+$1.25M	0.76%	43
2024 Q1	$13.7M	Sell	924,199 -20,059	-2%	-$270K	1.2%	32
2023 Q4	$13.7M	Sell	944,258 -536,044	-36%	-$5.48M	1.52%	21
2023 Q3	$16M	Buy	1,480,302 +62,500	+4%	+$752K	1.61%	24
2023 Q2	$18.3M	Buy	1,417,802 +137,500	+11%	+$1.86M	2.03%	14
2023 Q1	$16.9M	Buy	+1,280,302	New	+$20.3M	2.09%	15